Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q3 2020 Results - Earnings Call Transcript
10:34pm, Thursday, 05'th Nov 2020
Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q3 2020 Results - Earnings Call Transcript
Emergent Biosolutions (EBS) Q3 Earnings Top Estimates
07:40pm, Thursday, 05'th Nov 2020
Emergent Biosolutions (EBS) delivered earnings and revenue surprises of 6.83% and -14.75%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stoc
Emergent BioSolutions: Deep Value Play With 33% Upside & Military Exposure
03:19pm, Thursday, 29'th Oct 2020
Emergent BioSolutions has key niche differentiators that strengthen the operating model, with exposure to defence & public health threats. They hold the only FDA approved anthrax vaccine in their port
Opinion | Joe Biden’s Me-Too Covid Plan
11:02pm, Friday, 21'st Aug 2020
A mask mandate aside, Trump is already doing what Joe recommends.
FDA Nods to Emergent's (EBS) Narcan Shelf Life Extension
04:39pm, Tuesday, 18'th Aug 2020
Emergent's (EBS) Narcan nasal spray gets an FDA nod to extend its shelf life from two years to three years.
Insider Sells Emergent BioSolutions Stock
03:59pm, Tuesday, 18'th Aug 2020
Shares of Emergent BioSolutions Inc (NYSE:EBS) fell by 3.5% from the previous closing price. Harsanyi Zsolt filed a Form 4 with the SEC on Tuesday, August 18. The insider sold 6,609 shares at an avera
Emergent BioSolutions to Participate in Virtual Investor Conferences
10:31am, Tuesday, 18'th Aug 2020
GAITHERSBURG, Md., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following
Insider Sells Emergent BioSolutions Stock
12:00am, Tuesday, 18'th Aug 2020
Shares of Emergent BioSolutions Inc (NYSE:EBS) fell by 3.5% from the previous closing price. Harsanyi Zsolt filed a Form 4 with the SEC on Tuesday, August 18. The insider sold 6,...
UPDATE -- Emergent BioSolutions Announces FDA Approval of NARCAN® (naloxone HCl) Nasal Spray Shelf Life Extension to 36 Months
03:54pm, Monday, 17'th Aug 2020
GAITHERSBURG, Md., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the extension of the shelf lif
Has Emergent Biosolutions (EBS) Outpaced Other Medical Stocks This Year?
03:30pm, Monday, 17'th Aug 2020
Is (EBS) Outperforming Other Medical Stocks This Year?
Emergent BioSolutions Announces FDA Approval of NARCAN® (naloxone HCl) Nasal Spray Shelf Life Extension to 36 Months
10:30am, Monday, 17'th Aug 2020
GAITHERSBURG, Md., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the extension of the shelf lif
Emergent BioSolutions Could See Further Upside Gains
01:11pm, Thursday, 13'th Aug 2020
Most of the indicators are still bullish in this name, although some profit-taking may be occurring.
Indian drugmaker Biological E. to make substance used in J&J's potential COVID-19 vaccine
11:58am, Thursday, 13'th Aug 2020Did Hedge Funds Make The Right Call On Emergent Biosolutions Inc (EBS) ?
01:26pm, Wednesday, 12'th Aug 2020
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail invest
Emergent BioSolutions Announces Successful Completion of Offering of 3.875% Senior Unsecured Notes Due 2028
08:05pm, Friday, 07'th Aug 2020
GAITHERSBURG, Md., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) (the “Company”) announced today that it has completed its previously announced offering of $450 million i
